Cargando…

Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma

Multiple myeloma (MM) is a plasma cell malignancy that is accompanied by hypercalcemia, renal failure, anemia, and lytic bone lesions. Heparanase (HPSE) plays an important role in supporting and promoting myeloma progression, maintenance of plasma cell stemness, and resistance to therapy. Previous s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ostrovsky, Olga, Beider, Katia, Magen, Hila, Leiba, Merav, Sanderson, Ralph D., Vlodavsky, Israel, Nagler, Arnon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047783/ https://www.ncbi.nlm.nih.gov/pubmed/36980254 http://dx.doi.org/10.3390/cells12060913

Ejemplares similares

P854: EFFECT OF HPSE AND HPSE2 SNPS ON THE RISK OF DEVELOPING PRIMARY PARASKELETAL MULTIPLE MYELOMA
por: Ostrovsky, Olga, et al.
Publicado: (2023)

Identification of strong intron enhancer in the heparanase gene: effect of functional rs4693608 variant on HPSE enhancer activity in hematological and solid malignancies
por: Ostrovsky, Olga, et al.
Publicado: (2018)

The HPSE Gene Insulator—A Novel Regulatory Element That Affects Heparanase Expression, Stem Cell Mobilization, and the Risk of Acute Graft versus Host Disease
por: Ostrovsky, Olga, et al.
Publicado: (2021)

Disruption of innate defense responses by endoglycosidase HPSE promotes cell survival
por: Agelidis, Alex, et al.
Publicado: (2021)

A Phylogenetic analysis of Heparanase (HPSE) gene
por: Shaik, Abjal Pasha, et al.
Publicado: (2012)

Dissociation of DNA damage sensing by endoglycosidase HPSE
por: Agelidis, Alex, et al.
Publicado: (2021)

CMV Seropositive Status Increases Heparanase SNPs Regulatory Activity, Risk of Acute GVHD and Yield of CD34(+) Cell Mobilization
por: Ostrovsky, Olga, et al.
Publicado: (2021)

Association of polymorphisms in the heparanase gene (HPSE) with hepatocellular carcinoma in Chinese populations
por: Yu, Lixia, et al.
Publicado: (2017)

Chemoradiotherapy Increases Intratumor Heterogeneity of HPSE Expression in the Relapsed Glioblastoma Tumors
por: Suhovskih, Anastasia V., et al.
Publicado: (2020)

Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype
por: Beider, Katia, et al.
Publicado: (2014)

CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression
por: Beider, Katia, et al.
Publicado: (2022)

Lrig2 and Hpse2, mutated in urofacial syndrome, pattern nerves in the urinary bladder
por: Roberts, Neil A., et al.
Publicado: (2019)

Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response
por: Beider, Katia, et al.
Publicado: (2020)

Salvianolic acid B attenuates renal interstitial fibrosis by regulating the HPSE/SDC1 axis
por: Hu, Yang, et al.
Publicado: (2020)

Ischemic stroke disrupts the endothelial glycocalyx through activation of proHPSE via acrolein exposure
por: Ko, Kenta, et al.
Publicado: (2021)

Characterization of Cyclin E Expression in Multiple Myeloma and Its Functional Role in Seliciclib-Induced Apoptotic Cell Death
por: Josefsberg Ben-Yehoshua, Liat, et al.
Publicado: (2012)

miR-15b-5p Promotes Growth and Metastasis in Breast Cancer by Targeting HPSE2
por: Wu, Balu, et al.
Publicado: (2020)

CREB3 Plays an Important Role in HPSE-Facilitated HSV-1 Release in Human Corneal Epithelial Cells
por: Yadavalli, Tejabhiram, et al.
Publicado: (2022)

Novel Strategies for Immunotherapy in Multiple Myeloma: Previous Experience and Future Directions
por: Danylesko, Ivetta, et al.
Publicado: (2012)

Development of Novel Single-Stranded Nucleic Acid Aptamers against the Pro-Angiogenic and Metastatic Enzyme Heparanase (HPSE1)
por: Simmons, Suzanne C., et al.
Publicado: (2012)

Expanding the HPSE2 Genotypic Spectrum in Urofacial Syndrome, A Disease Featuring a Peripheral Neuropathy of the Urinary Bladder
por: Beaman, Glenda M., et al.
Publicado: (2022)

Single-Cell Sequencing Analysis and Multiple Machine Learning Methods Identified G0S2 and HPSE as Novel Biomarkers for Abdominal Aortic Aneurysm
por: Xiong, Tao, et al.
Publicado: (2022)

An Artificial miRNA against HPSE Suppresses Melanoma Invasion Properties, Correlating with a Down-Regulation of Chemokines and MAPK Phosphorylation
por: Liu, Xiaoyan, et al.
Publicado: (2012)

Correction: Development of Novel Single-Stranded Nucleic Acid Aptamers against the Pro-Angiogenic and Metastatic Enzyme Heparanase (HPSE1)
por: Simmons, Suzanne C., et al.
Publicado: (2012)

Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution
por: Jiménez-Segura, Raquel, et al.
Publicado: (2022)

The novel compound STK405759 is a microtubule-targeting agent with potent and selective cytotoxicity against multiple myeloma in vitro and in vivo
por: Rozic, Gabriela, et al.
Publicado: (2016)

Heparanase (HPSE) gene polymorphism (rs12503843) contributes as a risk factor for hepatocellular carcinoma (HCC): a pilot study among Egyptian patients
por: Saad, Faten, et al.
Publicado: (2021)

Tetramethylpyrazine Alleviates Endothelial Glycocalyx Degradation and Promotes Glycocalyx Restoration via TLR4/NF-κB/HPSE1 Signaling Pathway During Inflammation
por: Lei, Jin, et al.
Publicado: (2022)

STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in vivo multiple myeloma models
por: Rozic, Gabriela, et al.
Publicado: (2018)

Immunotherapy for Multiple Myeloma
por: Kröger, Nicolaus, et al.
Publicado: (2012)

Dissecting the mechanisms involved in anti-human T-lymphocyte immunoglobulin (ATG)-induced tolerance in the setting of allogeneic stem cell transplantation - potential implications for graft versus host disease
por: Beider, Katia, et al.
Publicado: (2017)

Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study
por: Shragai, Tamir, et al.
Publicado: (2022)

P889: POINT-OF-CARE ANTI-BCMA CAR T-CELL THERAPY INDUCES ENCOURAGING RESPONSE RATES IN HIGH-RISK RELAPSE/REFRACTORY MULTIPLE MYELOMA
por: Magen, Hila, et al.
Publicado: (2023)

Diagnosis and management of multiple myeloma during pregnancy: case report, review of the literature, and an update on current treatments
por: Magen, Hila, et al.
Publicado: (2022)

Heparanase—A single protein with multiple enzymatic and nonenzymatic functions
por: Vlodavsky, Israel, et al.
Publicado: (2023)

Forty Years of Basic and Translational Heparanase Research
por: Vlodavsky, Israel, et al.
Publicado: (2020)

Heparanase Promotes Engraftment and Prevents Graft versus Host Disease in Stem Cell Transplantation
por: Bitan, Menachem, et al.
Publicado: (2010)

Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell Malignancies
por: Beider, Katia, et al.
Publicado: (2022)

Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma
por: Keppler, Sarah, et al.
Publicado: (2016)

Randomized, placebo‐controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomib
por: Richardson, Paul G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p093pa1liiql8n2q5amc2kfv7i